Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
| Actual shortage: | 54 (12%) | |
| Anticipated shortage: | 15 (3%) | |
| Avoided shortage: | 8 (2%) | |
| Resolved: | 368 (83%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
12 (16%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| FLUOXETINE | 10MG | CAPSULE | Actual shortage | 2022-07-12 | 2024-05-06 | 164459 |
| FLUOXETINE | 20MG | CAPSULE | Actual shortage | 2022-07-12 | 2024-05-06 | 164462 |
| FLUOXETINE | 20MG | CAPSULE | Actual shortage | 2022-07-12 | 2024-05-06 | 164466 |
| MINOCYCLINE | 50MG | CAPSULE | Resolved | 2017-09-14 | 2019-01-22 | 22094 |
| MINOCYCLINE | 100MG | CAPSULE | Resolved | 2017-09-14 | 2019-01-22 | 22098 |
| AMOXICILLIN | 500MG | CAPSULE | Actual shortage | 2022-07-12 | 2022-12-16 | 164472 |
| AMOXICILLIN | 500MG | CAPSULE | Actual shortage | 2022-07-12 | 2022-12-16 | 164475 |
| GABAPENTIN | 100MG | CAPSULE | Resolved | 2017-12-15 | 2017-12-22 | 33110 |
| GABAPENTIN | 100MG | CAPSULE | Resolved | 2023-10-23 | 2023-11-14 | 207859 |
| GABAPENTIN | 100MG | CAPSULE | Resolved | 2024-01-30 | 2024-03-14 | 217766 |
| GABAPENTIN | 300MG | CAPSULE | Resolved | 2023-08-29 | 2023-10-23 | 203128 |
| GABAPENTIN | 300MG | CAPSULE | Resolved | 2023-11-22 | 2024-03-08 | 211055 |
| GABAPENTIN | 300MG | CAPSULE | Actual shortage | 2024-02-26 | 2024-02-27 | 220627 |
| GABAPENTIN | 400MG | CAPSULE | Resolved | 2017-10-10 | 2017-10-27 | 24913 |
| GABAPENTIN | 400MG | CAPSULE | Resolved | 2017-11-22 | 2017-12-22 | 30110 |
| GABAPENTIN | 400MG | CAPSULE | Actual shortage | 2024-03-25 | 2024-04-29 | 223259 |
| SERTRALINE | 25MG | CAPSULE | Resolved | 2021-03-17 | 2021-08-04 | 135815 |
| SERTRALINE | 25MG | CAPSULE | Resolved | 2023-07-17 | 2023-09-06 | 198792 |
| SERTRALINE | 25MG | CAPSULE | Actual shortage | 2024-01-17 | 2024-05-07 | 216264 |
| SERTRALINE | 50MG | CAPSULE | Resolved | 2021-03-17 | 2021-07-18 | 135812 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
| DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
| DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
| MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-04-08 | 2020-06-13 | 111515 |
| MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
| MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-06-03 | 111521 |
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151302 |
| BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151307 |